Glycomics or Glycobiology Market Growth Outlook Through 2024-2033

Overview and Scope
Glycomics, or glycobiology, refers to the study of the structure, biosynthesis, and biology of saccharides (including sugar chains or glycans) that are widely distributed in nature. Glycans are researched in glycobiology for their structure, production, and biology.

Sizing and Forecast
The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.59 billion in 2023 to $1.84 billion in 2024 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification..

The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.38 billion in 2028 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (ai) and data analytics, expansion in glycobiology-based drug development, integration of glycomics in disease biomarker discovery, personalized medicine and glycan-based therapeutics.. Major trends in the forecast period include cross-disciplinary collaborations, glycosylation patterns in disease mechanisms, innovative precision medicine and personalized therapies, advancements in glycoanalytical tools, glycans in immunotherapy and vaccines..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Segmentation & Regional Insights
The glycomics or glycobiology market covered in this report is segmented –

1) By Product: Enzymes, Kits, Reagents and Chemicals, Instruments, Carbohydrates
2) By Application: Drug Discovery and Development, Disease Diagnostics, Other Applications
3) By End-user: Academic Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical Laboratories

North America was the largest region in the glycomics or glycobiology market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8749&type=smp

Major Driver Impacting Market Growth
The increase in demand for medicines for the treatment of several severe chronic diseases is expected to propel the growth of the glycomics or glycobiology market going forward. Chronic diseases are health problems that are usually long-term and can be controlled but not healed. A glycomics study studies changes in glycosylation and its functions, which helps in the development of drugs and related medications for several severe chronic diseases. For instance, in 2022, according to Cancer Facts and Figures 2022–2024, a scientific paper by the American Cancer Society, there would be 22.5 million cancer (a chronic disease) survivors by 2032, which is projected to reach 26 million by 2040. Thus, the increase in demand for medicines for the treatment of several severe chronic diseases drives the glycomics or glycobiology market.

Key Industry Players
Major companies operating in the glycomics or glycobiology market report are Water Corporation, Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., S-BIO Pte. Ltd., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., Sumitomo Bakelite Co. Ltd., Bruker Corporation, AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., IEC Group Ltd., R&D Systems Inc.

The glycomics or glycobiology market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/ 
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model